Bill > H5853

This bill establishes the Wholesale Prescription Drug Importation Program in Rhode Island, designed to allow the state to import prescription drugs from Canada to reduce consumer costs. The program requires the executive office of health and human services to develop a comprehensive plan that includes designating a state agency to become or contract with a licensed drug wholesaler, using Canadian drug suppliers regulated by Canadian law, and ensuring only FDA-approved drugs are imported. The bill mandates that imported drugs must be expected to generate substantial consumer savings, cannot be distributed outside of Rhode Island, and must comply with federal drug tracing requirements. The state must apply for federal approval from the Department of Health and Human Services by May 1, 2026, and begin program operations within six months of receiving certification. Once implemented, the program will require creating a public website listing drug prices, developing a registration process for participating healthcare providers and insurers, establishing an outreach plan, and providing a consumer hotline. The state must also submit annual reports to the legislature detailing program specifics, including the number of drugs dispensed, participating entities, and estimated cost savings. The program aims to provide a structured, regulated method for accessing potentially lower-cost prescription drugs from Canada while maintaining safety and transparency.

Health and Social Services

https://status.rilegislature.gov/